Capricor Therapeutics (CAPR) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to -$274.7 million.
- Capricor Therapeutics' Retained Earnings fell 4254.39% to -$274.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$274.7 million, marking a year-over-year decrease of 4254.39%. This contributed to the annual value of -$199.8 million for FY2024, which is 2539.24% down from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' Retained Earnings is -$274.7 million, which was down 4254.39% from -$250.1 million recorded in Q2 2025.
- Over the past 5 years, Capricor Therapeutics' Retained Earnings peaked at -$93.2 million during Q1 2021, and registered a low of -$274.7 million during Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was -$152.2 million (2023), whereas its average is -$158.5 million.
- In the last 5 years, Capricor Therapeutics' Retained Earnings plummeted by 1625.88% in 2023 and then tumbled by 4254.39% in 2025.
- Over the past 5 years, Capricor Therapeutics' Retained Earnings (Quarter) stood at -$108.1 million in 2021, then fell by 26.85% to -$137.1 million in 2022, then fell by 16.26% to -$159.4 million in 2023, then decreased by 25.39% to -$199.8 million in 2024, then plummeted by 37.47% to -$274.7 million in 2025.
- Its Retained Earnings stands at -$274.7 million for Q3 2025, versus -$250.1 million for Q2 2025 and -$224.2 million for Q1 2025.